LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
LLY
902.74
-0.9%↓
UNH
596.8
+0.31%↑
NVO
131.05
+0.18%↑
JNJ
164.37
-0.29%↓
ABBV
193.18
+0.34%↑
Übersicht
Veränderung der Aktienkurses
24h
Aktuell
Min
82.94
Max
83.26
Empfehlungen | Starkes Kaufsignal |
---|---|
12-Monats-Prognose | +6.27 upside |
Technischer Score
By Trading Central
Vertrauen
Very Strong Bearish Evidence
82.46 / 87.21 Unterstützung & Widerstand
AstraZeneca PLC ADR Chart
Ähnliche Nachrichten
25. Juli 2024, 09:17 UTC
AstraZeneca Raises Guidance After Results Beat Market Expectations -- Update
DJ
Lesen
25. Juli 2024, 06:48 UTC
AstraZeneca Raises Guidance After Revenue, Earnings Beat Market Expectations
DJ
Lesen
12. Juli 2024, 19:57 UTC
Instil Bio Shares Surge Following Rental Agreement with AstraZeneca
DJ
Lesen
5. Sept. 2024, 13:00 UTC
China Detains AstraZeneca Employees Over Alleged Transport of Unapproved Drug -- WSJ
DJ
Lesen
29. Juli 2024, 10:30 UTC
Big Pharma Rallies and Moves Past Obesity -- Heard on the Street -- WSJ
DJ
Lesen
25. Juli 2024, 13:20 UTC
AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD
DJ
Lesen
25. Juli 2024, 09:21 UTC
AstraZeneca's Guidance Lift Is Conservative; Risks to Upside -- Market Talk
DJ
Lesen
25. Juli 2024, 07:05 UTC
AstraZeneca Guidance Raise Signals Portfolio Potential -- Market Talk
DJ
Lesen
25. Juli 2024, 06:06 UTC
AstraZeneca Increased Interim Dividend by 7c to $1.00
DJ
Lesen
25. Juli 2024, 06:04 UTC
AstraZeneca Had Seen Core EPS Grow by Low Double-Digit to Low Teens Percentage Range
DJ
Lesen
25. Juli 2024, 06:04 UTC
AstraZeneca Had Seen Total Revenue Grow by Low Double-Digit to Low Teens Percentage Range
DJ
Lesen
25. Juli 2024, 06:04 UTC
AstraZeneca Sees Core EPS Growth in 2024 by Mid Teens Percentage Range At Constant Currency
DJ
Lesen
25. Juli 2024, 06:04 UTC
AstraZeneca Sees Total Revenue Growth in 2024 by Mid Teens Percentage Range At Constant Currency
DJ
Lesen
25. Juli 2024, 06:03 UTC
AstraZeneca Raises 2024 View
DJ
Lesen
25. Juli 2024, 06:02 UTC
AstraZeneca 2Q Revenue Consensus Was $12.7B
DJ
Lesen
25. Juli 2024, 06:02 UTC
AstraZeneca 2Q Core EPS Consensus Was $1.95
DJ
Lesen
25. Juli 2024, 06:00 UTC
AstraZeneca PLC 2Q Adj EPS $1.98
DJ
Lesen
25. Juli 2024, 06:00 UTC
AstraZeneca PLC 2Q Pretax Pft $2.4B
DJ
Lesen
25. Juli 2024, 06:00 UTC
AstraZeneca PLC 2Q Rev $12.94B
DJ
Lesen
25. Juli 2024, 06:00 UTC
AstraZeneca PLC 2Q Oper Pft $2.75B
DJ
Lesen
25. Juli 2024, 06:00 UTC
AstraZeneca PLC 2Q Net Pft $1.93B
DJ
Lesen
25. Juli 2024, 06:00 UTC
AstraZeneca PLC 2Q EPS $1.24
DJ
Lesen
15. Juli 2024, 06:04 UTC
AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone
DJ
Lesen
15. Juli 2024, 06:04 UTC
AstraZeneca: Amolyt Pharma's Hldrs Eligible to Receive $250M On Achieving Specific Milestone
DJ
Lesen
15. Juli 2024, 06:02 UTC
AstraZeneca: Acquisition Includes $800M Upfront at Deal Closing
DJ
Lesen
15. Juli 2024, 06:02 UTC
AstraZeneca: Amolyt Pharma's Total Consideration of Up to $1.05B
DJ
Lesen
15. Juli 2024, 06:01 UTC
AstraZeneca: Acquisition Bolsters Alexion Rare Disease Late-Stage Pipeline
DJ
Lesen
15. Juli 2024, 06:00 UTC
AstraZeneca Completes Acquisition of Amolyt Pharma
DJ
Lesen
15. Juli 2024, 06:00 UTC
AstraZeneca PLC Acquisition of Amolyt Pharma completed
DJ
Lesen
15. Juli 2024, 06:00 UTC
AstraZeneca PLC Acquisition of Amolyt Pharma completed
DJ
Lesen
Peer-Vergleich
Kursveränderung
AstraZeneca PLC ADR Prognose
Kursziel
By TipRanks
12-Monats-Prognose
Durchschnitt 88.26 USD 6.27%
Hoch 99 USD
Tief 74 USD
Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für AstraZeneca PLC ADR – Dist angeboten haben.
Rating-Konsens
By TipRanks
Starkes Kaufsignal
6 ratings
5
Buy
1
Halten
0
Sell
Basierend auf 6 Analysten, die in den letzten 3 Monaten Aktienbewertungen für AstraZeneca PLC ADR – Dist abgegeben haben.
Technischer Score
By Trading Central
Kurzfristig
Very Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Mittelfristig
Bearish Evidence
Recent bearish events outweigh bullish events.
Langfristig
No Evidence
There are no events.